Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125211) titled 'Multi-parameter and Radiomics Combined with Clinical Features of 18F-FDGPET/CT: A Single-center Clinical Study (Retrospective Clinical Study) on Efficacy Evaluation and Risk Stratification Prediction Model Construction for Diffuse Large B-Cell Lymphoma Treated with Polatuzumab-containing Regimens' on May 22.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: West China Hospital of Sichuan University
Condition:
Diffuse Large B-Cell Lymphoma
Intervention:
Modeling group:none
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-05-22
Target ...